Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LiSWT with Xiaflex for Peyronie's Disease
NCT06065436Recruiting
- Sponsor
- Mayo Clinic
- Start
- Jan 2024
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Randomised trial in Peyronie's disease (2 arms), sponsored by Mayo Clinic. Primary endpoints: Change in symptom bother at 6 weeks, Change in penetrative sexual intercourse at 6 weeks and 3 more. Started Jan 2024; status: recruiting.
02
Conditions
Peyronie's disease
Beyond the preview
Go deeper on NCT06065436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06065436.